Roman Health Ventures Inc. acquired PREBOOST Business of Veru Inc. from Veru Inc. (NasdaqCM:VERU) for $20 million on December 9, 2020. The consideration is fully payable in cash and consists of $15 million paid at closing, $2.5 million payable 12 months after closing and $2.5 million payable 18 months after closing. The PREBOOST Business recorded revenue of $785,283 for three months ended September 30, 2020. Proceeds from the transaction, along with current cash and anticipated cash flow from operations, are expected to be sufficient to self-fund Veru's existing drug product development program. Roman Health Ventures Inc. completed the acquisition of PREBOOST Business of Veru Inc. from Veru Inc. (NasdaqCM:VERU) on December 9, 2020.